The Risk Management Plan Summit 2017 covers topics such as:
- App/technological tool as a medium to monitor and track activities at the local level
- Regulations globally including EMA’s GVP Modules V and XVI
- Tailor communications to the needs of specific patients with disparate backgrounds
- Implement and harmonise on a global scale from a regional or centralised model with cross-functional teams
- Drug safety and patient outcomes and incorporate analysis into modifications
The Risk Management Plan Summit 2017 brings together attendees from pharmaceutical and biotechnology companies responsibile for:
- Epidemiology/Pharmacoepidemiology
- Benefit/Risk Management
- Biostatistics
- Global/Regional Pharmacovigilance
- Risk Analysis/Assessment
- Medical Writing
- Local/Regional Medical Safety
- Global Drug/Product Safety
- Medical Information
- Safety Evaluation/Reporting
- Therapy Area Safety
- Patient Safety
- Safety Surveillance/Operations
- Integrated Medical Safety
- Clinical Risk Management
- Clinical Data Management
- Compliance Management
- Regulatory Affairs/Legal
- Pre/Post Marketing
- Patient Engagement
- Life Cycle Management